173 related articles for article (PubMed ID: 29482394)
1. Synthesis and biological evaluation of N-arylpiperazine derivatives of 4,4-dimethylisoquinoline-1,3(2H,4H)-dione as potential antiplatelet agents.
Marcinkowska M; Kotańska M; Zagórska A; Śniecikowska J; Kubacka M; Siwek A; Bucki A; Pawłowski M; Bednarski M; Sapa J; Starek M; Dąbrowska M; Kołaczkowski M
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):536-545. PubMed ID: 29482394
[TBL] [Abstract][Full Text] [Related]
2. Anti-aggregation effect of aroxyalkyl derivatives of 2-methoxyphenylpiperazine is due to their 5-HT
Kubacka M; Kazek G; Kotańska M; Filipek B; Waszkielewicz AM; Mogilski S
Eur J Pharmacol; 2018 Jan; 818():263-270. PubMed ID: 29111111
[TBL] [Abstract][Full Text] [Related]
3. Novel serotonin 5-HT
Czopek A; Kubacka M; Bucki A; Siwek A; Filipek B; Pawłowski M; Kołaczkowski M
Pharmacol Rep; 2021 Oct; 73(5):1361-1372. PubMed ID: 34115343
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro cytotoxicity and biological evaluation of twenty novel 1,3-benzenedisulfonyl piperazines as antiplatelet agents.
Liu XJ; Wang Y; Wang X; Zhang ZH
Bioorg Med Chem; 2021 Sep; 46():116390. PubMed ID: 34500186
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of antiplatelet 2-aminochromones.
Morris J; Wishka DG; Lin AH; Humphrey WR; Wiltse AL; Gammill RB; Judge TM; Bisaha SN; Olds NL; Jacob CS
J Med Chem; 1993 Jul; 36(14):2026-32. PubMed ID: 8336341
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
Wang WY; Hsieh PW; Wu YC; Wu CC
Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
[TBL] [Abstract][Full Text] [Related]
7. The synthesis of 4,7-disubstituted-2H-benzo[b][1,4]-oxazin-3(4H)-ones using Smiles rearrangement and their in vitro evaluation as platelet aggregation inhibitors.
Xia S; Liu JQ; Wang XH; Tian Y; Wang Y; Wang JH; Fang L; Zuo H
Bioorg Med Chem Lett; 2014 Mar; 24(6):1479-83. PubMed ID: 24565904
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis of novel tryptophan derivatives for antiplatelet aggregation activity based on tripeptide pENW (pGlu-Asn-Trp).
Xie Z; Feng S; Wang Y; Cao C; Huang J; Chen Y; Kong Y; Li Z
Eur J Med Chem; 2015 Sep; 102():363-74. PubMed ID: 26298494
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
[TBL] [Abstract][Full Text] [Related]
10. Pyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation.
Levent S; Çalışkan B; Çiftçi M; Özkan Y; Yenicesu I; Ünver H; Banoglu E
Eur J Med Chem; 2013 Jun; 64():42-53. PubMed ID: 23639653
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of 4-methoxy-3-arylamido-N-(substitutedphenyl)benzamide derivatives as potential antiplatelet agents.
Liu X; Chen X; Qiu K; Zhang Z
Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900231. PubMed ID: 31808975
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet activity of synthetic pyrrolo-benzylisoquinolines.
Kuo RY; Wu CC; Chang FR; Yeh JL; Chen IJ; Wu YC
Bioorg Med Chem Lett; 2003 Mar; 13(5):821-3. PubMed ID: 12617899
[TBL] [Abstract][Full Text] [Related]
14. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
[TBL] [Abstract][Full Text] [Related]
15. Adrenergic receptor polymorphisms and platelet reactivity after treatment with dual antiplatelet therapy with aspirin and clopidogrel in acute coronary syndrome.
Cuisset T; Hamilos M; Delrue M; Frère C; Verhamme K; Bartunek J; Saut N; Bonnet JL; Eijgelsheim M; Wijns W; Alessi MC; Barbato E
Thromb Haemost; 2010 Apr; 103(4):774-9. PubMed ID: 20135061
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antiplatelet and in silico evaluations of novel N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides.
Jordão AK; Ferreira VF; Lima ES; de Souza MC; Carlos EC; Castro HC; Geraldo RB; Rodrigues CR; Almeida MC; Cunha AC
Bioorg Med Chem; 2009 May; 17(10):3713-9. PubMed ID: 19380229
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and the Evaluations in vitro Antiplatelet Aggregation Activities of 4-Ethoxyisophthalamides.
Liu XJ; Shi TE; Wang X; Wei TT; Meng X
Cardiovasc Hematol Agents Med Chem; 2015; 13(2):124-8. PubMed ID: 26695422
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
[TBL] [Abstract][Full Text] [Related]
19. Rational Design and Synthesis of 1-(Arylideneamino)-4-aryl-1H-imidazole-2-amine Derivatives as Antiplatelet Agents.
Amidi S; Esfahanizadeh M; Tabib K; Soleimani Z; Kobarfard F
ChemMedChem; 2017 Jun; 12(12):962-971. PubMed ID: 28494138
[TBL] [Abstract][Full Text] [Related]
20. Non-peptide glycoprotein IIb/IIIa antagonists. 11. Design and in vivo evaluation of 3,4-dihydro-1 (1H)-isoquinolinone-based antagonists and ethyl ester prodrugs.
Hutchinson JH; Cook JJ; Brashear KM; Breslin MJ; Glass JD; Gould RJ; Halczenko W; Holahan MA; Lynch RJ; Sitko GR; Stranieri MT; Hartman GD
J Med Chem; 1996 Nov; 39(23):4583-91. PubMed ID: 8917647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
